C-FMVGAdaptyv Biosystems
protein validation, automated lab, protein engineering
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-FMVG
C-FMVGC-FMVGprotein validation, automated lab, protein engineering
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Why does the Phase I clinical trial failure rate remain stubbornly stuck at 90% despite an abundance of foundation models and biological data? Hear it from those in charge. Recorded live on June 18th, 2026, at Google Zurich's Forum Escher, this panel sits down with life science pioneers to separate reality from the noise. We explore the infrastructure bottleneck in computational biology, the logic of extracting actionable insights from fragmented data silos, and the strategic evolution required to turn experimental assets into validated clinical outcomes. The Panel: Noushin Hadadi – Chief Data Officer at Novigenix A Julian Englert – CEO & Co-founder at Adaptyv Bio\ Peter Nestorov – CEO & Co-founder at Scailyte Guillermo Tramontin (Moderator) – Associate Partner at Cavenagh Health
*This video was recorded at Foresight's Molecular Systems Design Workshop 2023.* https://foresight.org/foresight-molecular-systems-design-workshop-2023/ *Julian Englert, Adaptyv Bio* *Making a Protein Printer That Turns Bits Into Molecules* https://www.linkedin.com/in/julian-englert/ Complex molecular machines system design could be sped up by integrating emerging approaches and advancements on the software and simulation-side. Some areas were highlighted by our 2022 workshop, some are entirely new. This two-day event invites leading researchers, entrepreneurs, and funders to put the pieces together and drive progress towards the original vision of nanotechnology: creating reprogrammable tools that can create individually specified chemical bonds at scale. Explore new opportunities, form lasting collaborations, and join us in cooperating on shared long-term goals of the Molecular Machines space. *The Foresight Institute* is a research organization and non-profit that supports the b
Molecule — Reduce Friction, Accelerate Science Discover Blog Resources About Launch App Connect Introducing Labs Reduce friction, accelerate science Labs brings funding, collaboration, and visible progress into one shared platform, helping scientific projects move forward with less friction. Discover Projects $ 0 M Ecosystem Market Cap 1 (source 1 ) $ 0.0 M+ Research Funded 2 (source 2 ) 0 + Projects Launched 3 (source 3 ) 0 K+ Community Members 4 (source 4 ) 1 . Dune Analytics / 2 . Dune Analytics / 3 . Dune Analytics / 4 . Molecule X Community Funders access early stage research before it hi
News MENU CLOSE Manifesto Portfolio Team News Contact SUBSCRIBE Subscribe with your email to get the latest news and updates. ACE Ventures Signup SUBSCRIBE Jobs Founders Investors SUBSCRIBE × SUBSCRIBE Subscribe with your email to get the latest news and updates. ACE Ventures Signup SUBSCRIBE NEWS & INSIGHTS Tracking our momentum—explore key moves, portfolio wins, and strategic insights as we grow, build, and back bold ventures. ACE Ventures Leads $8 Million Seed Round in Adaptyv Bio to Accelerate the Future of Protein Design 25/09/2025 ACE Ventures led the $8 million seed round in Adapty … de Picciotto,... Ex-Uber Exec Joins ACE & Company To Launch Venture Capital Fund Focused on Swiss Technology 4/03/2023 | News & Insights Steve Salom, former Uber Executive, is joining ACE & Company, a leading global private equity and venture capital firm, as a Partner to co-run... Next Entries » for investors Our team’s track record is rooted in building — not just betting. connect with us FOR FOUNDERS You bring the vision. We bring expertise, and capital t
Artiva Biotherapeutics - aVenture Company Research Home Research Loading aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions. aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our da
ConvergeAB Generates Stronger EGFR Antibody Than Cradle Design | Iddo Weiner posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, yo … Buchanan FRSC 2mo Report this comment Will have a read. Sounds a really useful application. Thanks Like Reply 4 Reactions 5 Reactions Tal S. 2mo Report this comment Thanks for sharing this. Curious to know how this model and other AI-powered models will transform the field. Like Reply 3 Reactions 4 Reactions Dr. Reza Rahavi 2mo Report this comment Impressive work! Do you think this approach can be extended to other therapeutic targets beyond EGFR? Like Re
Scientific Skills — AI Agent Skill by K-Dense-AI | AgenticSkills Index live · v 1.3.0 · JUN 8 2026 181 + skills indexed 200+ MCP servers 18+ platforms tracked [ ⌘K ] search Skills MCP Servers Workflows Learn Search 181 skills... ⌘K Submit a Skill Home Data Science Scientific Skills Scientific Skills B -rank by K-Dense-AI Comprehensive collection of scientific skills for specialized libraries and databases. Claude Code 27.6K stars Updated 11 hours ago 11 contributor s Install This Skill CLI Manual Claude Code npx skills add K-Dense-AI/claude-scientific-skills # Download SKILL.md and place in yo … tein screening experiments, BLI/SPR assays, thermostability assays, or wants to submit protein sequences for experimental characterization. Also trigger when code imports `adaptyv`, `adaptyv_sdk`, or `FoundryClient`, or references `foundry-api-public.adaptyvbio.com`. skills/adaptyv aeon This skill should be used for time series machine learning tasks including classification, regression, clustering, forecasting, anomaly detection, segmentation, and similarity search. Use when … r multi-database Python workflows use bioservices. skills/gget ginkgo-cloud-lab Submit and manage protocols on Ginkgo Bioworks Cloud Lab (cloud.ginkgo.bio), a web-based interface for autonomous lab execution on Reconfigurable Automation Carts (RACs). Use when the user wants to run cell-free protein expression (validation or optimization), generate fluorescent pixel art, or interact with Ginkgo Cloud Lab services. Covers protocol selection, input preparation, pricing, and orde … ion. skills/matplotlib medchem Medicinal chemistry filters for compound triage. Apply drug-likeness rules (Lipinski, Veber, CNS), structural alert catalogs (PAINS, NIBR, ChEMBL), complexity metrics, and the medchem query language for library filtering. skills/medchem modal Modal is a serverless cloud platform for running Python on demand, including on-demand GPUs. Use when deploying or serving AI/ML models, running GPU-accelerated workloads (training, fine-tuning, inference), … nt samplesheets, prepare reproducible Nextflow launch artifacts, run locally or submit to schedulers (LSF/Slurm/PBS/SGE), and triage execution failures. Triggers on requests to run pacsomatic, prepare launch commands/scripts, perform dry-run checks, or troubleshoot pipeline startup and scheduler submission errors. skills/pacsomatic paper-lookup S
Pharmaceutical Services - Skip to content Home Services Menu Toggle Services-Software Development Services-Technologies Services-IT Staffing Services-IT Consulting Services-Cloud Services Pharmaceutical Services Medical Billing Services About Us Contact Us Main Menu Home Services Menu Toggle Services-Software Development Services-Technologies Services-IT Staffing Services-IT Consulting Services-Cloud Services Pharmaceutical Services Medical Billing Services About Us Contact Us Pharmaceutical Services Adaptyv Bio launched a protein engineering foundry, leveraging Gen AI, open-source software, … reduce the time to clinic for new medicament candidates. The FDA cleared an IND application for A2A Pharma’s AI-discovered TACC3 PPI inhibitor for women’s cancer. Insilico’s AI-generated drug, INS018_055, entered a Phase 2 study for idiopathic pulmonary fibrosis. UCF researchers introduced an AI-assisted technology for drug-target affinity projections. Pharos iBio developed an AI-driven anticancer medication addressing the FLT3 gene mutation. These examples are concrete evide … , ultimately expediting the pace of pharmaceutical innovations. Practical Application: By applying AI and data science, Sanofi has accelerated its drug discovery process and enhanced clinical research design. The company also boosted probable target identification in immunology, oncology, and neurology by 20% to 30%. This integration of artificial intelligence in mRNA research reduced the selection time for lipid nanoparticles from months to mere days. Furthermore, Sano … nology upholds quality standards and helps in maintaining guidelines. Practical Application: Sanofi is effectively utilizing Generative AI in its manufacturing and supply operations. The company has digitized quality assessment, enhancing precision and effectiveness. This technological integration has enabled the company to optimize its yield, leading to more efficient raw material usage. Notably, the adoption of AI has allowed Sanofi to accurately predict 80% of low inventor
false FY 0002010788 Yes Yes http://fasb.org/us-gaap/2024#LeaseholdImprovementsMember 0002010788 2024-01-01 2024-12-31 0002010788 2025-03-31 0002010788 2024-06-30 0002010788 2024-12-31 0002010788 2023-12-31 0002010788 2023-01-01 2023-12-31 0002010788 us-gaap:GrantMember 2024-01-01 2024-12-31 0002010788 us-gaap:GrantMember 2023-01-01 2023-12-31 0002010788 us-gaap:CommonStockMember 2023-12-31 0002010788 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0002010788 us-gaap:RetainedEarningsMember 2023-12-31 0002010788 us-gaap:CommonStockMember 2022-12-31 0002010788 us-gaap:AdditionalPaidInCapitalMemb … eding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,&# … You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Annual Report on Form 10-K. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Annual Report on Form 10-K.   Important factors that could cause di … and our ability to stay in compliance with laws and regulations that currently apply or become applicable to our business and those of the partner companies;         ● our ability to protect their and our respective intellectual property;         ● our relationships with our employees, clients and service providers;     ● our ability to identify, complete and integrate potential strategic acquisitions of com … -molecules in biofuels. Just to mention a few of the at least 100s of potential application areas we foresee that our core technology can be used for eventually.   All application areas represent large potential business opportunities. Focusing our efforts will be key. Focus will come from getting the order of the different addressable marke
A Protein Printer - by Asimov Press and Adaptyv Bio Asimov Press Subscribe Sign in Archive A Protein Printer How to make a machine that turns bits into molecules. Asimov Press and Adaptyv Bio Jul 11, 2023 67 10 23 Share I. Dreams This essay is a thought experiment about a protein printer , a new technology to convert digital bits into physical molecules . It is speculative writing, because this printer doesn’t yet exist. But there are no physical reasons that it couldn’t, and we think it could change biology as much as printers changed the news. We are living through an inflection point in bio … tellectual holes, but we hope you’ll reach out and leave comments. This isn’t a grant proposal; it’s just us speculating about how to solve a problem, much like we would at the bar on a Friday night. After all, that’s the place where many scientific ideas first take form and begin their slow journey toward reality. Note from our sponsor Fifty Years supports early-stage founders solving the world’s biggest problems. Their Fifty 50 program teaches entrepreneurial PhDs/postdocs … ying to solve the third part. They are building a foundry, where scientists can submit protein designs via an API and have them tested on automated workcells. By miniaturizing protein synthesis and characterization, and removing manual steps from the process, they aim to bring down the cost of protein engineering and help more people design proteins. Still, the major obstacle in testing more proteins is the cost of DNA. So let’s see how our method compares. A living cell burn … DNA sequencers already use immobilized proteins on a grid. But who is going to fund all of this? Maybe Speculative Technologies or Schmidt Futures have the money and desire. Or, perhaps, you are reading this and know how to make it all work — a solution has floated into your mind — and you’re buzzing to get started. We hope that’s true, because it would validate the entire notion that speculative writing can still drive progress forward. So what are you waiting for? Let’s gi … and length of contiguously synthesized DNA, would mostly solve the issues this proposal is trying to overcome. I agree that most new DNA synthesis companies aren't trying to compete on price, only length or turnaround time. Until we get past the crude hack of assembling hundreds of oligos together, that won't change, though we are working on tha
Adaptyv Raises CHF 6,40 million to Accelerate AI-Driven Protein Validation - BioAlps Skip to content Bio Alps FIND A HEALTH VALLEY ACTOR Menu Search News BioAlps news BioAlps 20 years Events About Mission Organization Members and Strategic Partners BioAlps Awards Media Center News Events BioAlps events Life science events About Mission Organisation Executive Committee BioAlps Team -- Members and Strategic Partners BioAlps Awards Media Centre Publication -- --> BioAlps Event Formats Business Opportunities Community Membership Registration The BioAlps Community Business opportunities Community M
ACE Ventures Leads $8 Million Seed Round in Adaptyv Bio to Accelerate the Future of Protein Design - ACE Ventures MENU CLOSE Manifesto Portfolio Team News Contact SUBSCRIBE Subscribe with your email to get the latest news and updates. ACE Ventures Signup SUBSCRIBE Jobs Founders Investors SUBSCRIBE × SUBSCRIBE Subscribe with your email to get the latest news and updates. ACE Ventures Signup SUBSCRIBE News & Insights ACE Ventures Leads $8 Million Seed Round in Adaptyv Bio to Accelerate the Future of Protein Design Backing the next-generation protein foundry that empowers scientists to design
%PDF-1.4 %���� 1 0 obj > /LastModified (��D:20241126173455Z) /PageUIDList > /PageItemUIDToLocationDataMap > /NumberofPages 1 /DocumentID (��xmp.did:a48c4a56-0195-a649-a5a7-e598d666cd1c) /OriginalDocumentID (��xmp.did:ec959455-5daa-0c4a-b95a-8057bb9605d6) /PageTransformationMatrixList > /NumberOfPageItemsInPage 65 >> >> /TrimBox [0.0000 0.0000 612.0000 792.0000] /Rotate 0 /Resources > /Font > /ExtGState > /ProcSet [/PDF /Text] >> /CropBox [0.0000 0.0000 612.0000 792.0000] /Contents 3509 0 R /Parent 278 0 R /ArtBox [0.0000 0.0000 612.0000 792.0000] /BleedBox [0.0000 0.0000 612.0000 792.0000] /Me … 422df7779 xmp.did:6c5217b8-24bd-7948-9b5b-954f3ae1ddcb proof:pdf converted from application/x-indesign to application/pdf Adobe InDesign 19.2 (Macintosh) / 2024-04-29T11:47:42-04:00 saved xmp.iid:b908408c-52f4-784a-8b27-0a9f585e99ca 2024-10-08T12:37:35-04:00 Adobe Illustrator 28.7 (Windows) / saved xmp.iid:6c5217b8-24bd-7948-9b5b-954f3ae1ddcb 2024-11-08T14:50:57-05:00 Adobe Illustrator 29.0 (Windows) / uuid:b860e620-59dc-49b4-a2c8-8b3b56cc23aa xmp.did:b35ab477-e056-4a4d-a77d- … 6-4a4d-a77d-e061d8d3f6b3 xmp.did:4cee3e84-7f38-474b-9b93-9f6422df7779 proof:pdf application/pdf HamburgGeometric Adobe PDF library 17.00 False 1 False False 17.177576 11.000000 Inches Cyan Magenta Yellow Black Default Swatch Group 0 Adobe Illustrator 72951573 Helvetica Now Text OpenType - PS 72951573 Monotype Typography 0 HelveticaNowText-Regular 1.00 2918577186 Helvetica Now Text OpenType - PS 2918577186 Monotype Typography 0 HelveticaNowText-Black 1.00 1538418053 Helvetica … q���Қ^ ��v#ˡ�j�i���C����8-��0�x�O���{ endstream endobj 22 0 obj > stream application/pdf OrgType 2024-11-11T21:54:39-05:00 2024-11-11T21:54:39-05:00 2024-11-11T21:54:39-04:00 Adobe Illustrator 29.0 (Windows) uuid:2002d8ba-3b0f-4dce-91bd-1a7453bc288c xmp.did:ac381879-e372-b14b-b6b9-788efb394a1d uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:c9914b06-205d-4060-b620-fae57f2f5102 xmp.did:526773d2-a98f-654f-bf01-cbbe9b3a6f9d uuid:5D20892493BFDB11914A8590D31508C8 proof … 00 Adobe PDF library 17.00 endstream endobj 23 0 obj > endobj 24 0 obj > stream application/pdf PrimaryJobFunciton 2024-11-11T19:56:02-05:00 2024-11-11T19:56:02-05:00 2024-11-11T19:56:01-04:00 Adobe Illustrator 29.0 (Windows) uuid:359aebf8-3551-4183-8785-cc6685800577 xmp.did:5bb7c1ca-7dc3-b24d-8320-dd41e97c253b uuid:5D20892493BFDB11914A8590D31508
�u���� | 18th Annual PEGS Europe - Protein & Antibody Engineering Summit 2026 �����T�C�g �A�W�F���_ �v���O���� �u���� ��u�� �V���[�g�R�[�X �g���[�j���O�Z�~�i�[ �o�Ȏ҃��X�g ���E�̐� �X�|���T�[/�o�W�� �X�|���T�[ �o�W�҃t���A�v���� �J�Òn �|�X�^�[ ���₢���킹 ���\������ Warning! Web API Url is not set for the Speaker Bios. �u���� Filter by: Last Name A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Organization 92bio A-Alpha Bio Aarhus University Abalone Bio Inc AbbVie Cambridge Research Center AbTx Accession Therapeutics Inc. Adaptyv Biosystems ADAXION Therapeutics Adimab Adimab LLC Affilogic AI Pr … the California Institute of Technology. In 2009, he pursued an NIH Postdoctoral fellowship at the Massachusetts Institute of Technology, working alongside Robert Langer and Dan Anderson. In 2013, he joined the Cornell faculty as an Assistant Professor in the School of Chemical and Biomolecular Engineering. His early research achievements include investigations into synthesis and properties of novel sequence-defined macromolecules, recognized through accolades such as the PhRM … les, recognized through accolades such as the PhRMA Foundation Research Starter Award, NSF CAREER Award, Cornell Engineering Research Excellence Award, the PMSE Young Investigator Award and was recently elected to the AIMBE College of Fellows. Acknowledging his commitment to teaching and mentorship, he received the 2017 Tau Beta Pi Professor of the Year Award and, more recently, the 2022 Richard F. Tucker Excellence in Teaching Award. Research conducted in the Alabi lab is fo … or conformational changes. She subsequently completed a three-year postdoctoral fellowship at the University of Fribourg (Switzerland), where she expanded her expertise to coarse-grained simulations, studying the biophysical properties of membrane tubules and vesicles, while further developing her skills in protein-membrane all-atom MD simulations. She currently works at Novartis, applying advanced computational techniques to investigate protein, siRNA and membrane behavior i … 2 journals. She has received more 45 awards, among them the �gNational Research Award�h, considered as the highest distinction from the Spanish Government, the Jaume I Award and the Founders, WIS and Outstanding Service Awards of the CRS, Inc. She is a member of 5 Academies in Spain and of the Royal Academy of Medicine of Belgium, the Academy of
Adaptyv Biosystems Remote Jobs | Remotli remot li Find Jobs Companies Guide About Post a Job ← All companies A Adaptyv Biosystems Hybrid biotech startup (<50) About This profile is auto-generated from public job data. Add your company story → Open Roles Adaptyv Biosystems hires remotely but their roles aren't auto-listed on Remotli yet. Check their careers page for current openings. View open roles on Adaptyv Biosystems 's careers page → Company Info Remote Policy Hybrid Size startup (<50) HQ Lausanne (Epalinges), Switzerland Website www.adaptyvbio.com ↗ Is this your company? A
Beyond Numbers: Unpacking the Rich History of the J.P. Morgan Healthcare Conference Scroll Top Menu Close About us Overview Leadership Team Board of Directors Clinical Advisory Board Partners Careers Science and Technology Platform Technology Science Posters Publications Pipeline Investors & Media Overview News & Events Stock Information Analyst Coverage Investor Resources SEC Filings Governance Documents Contact Us Perspectives Events and Team Interviews Parkinson 101 Technical Articles Menu Close About us Overview Leadership Team Board of Directors Clinical Advisory Board Partners
Jobs at Adaptyv Biosystems | Consider You are using an outdated browser. Please upgrade your browser to improve your experience and security. Home Sign In Powered by Consider Privacy Terms
Tamarind Bio Selected for TuneLab2.0 Inference Infrastructure | Deniz Kavi posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you
European RosettaCon - Rosetta Commons Skip to content Menu About About Us Diversity Labs Our Funders Software Software Overview Download & Support User & Developer Resources Licensing FAQ Education Workshops Learning Resources Foldit Undergraduates Postbaccalaureates Graduate Programs Events Events & Workshops Summer RosettaCon RosettaCon Brazil RosettaCon Asia European RosettaCon Winter RosettaCon Community News Jobs Newsletter Membership Grants for Members Policies Past Service & Awards Menu About About Us Diversity Labs Our Funders Software Software Overview Download � … rs Platinum Sponsor Gold Sponsor Silver Sponsors Bronze Sponsors Special Poster Prize Organizational Sponsors Questions or Comments? Please Contact Us . Contact Us | Code of Conduct © 2026 Rosetta Commons. All rights reserved. Manage Consent To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenti
Jobs at Adaptyv Biosystems | Founderful You are using an outdated browser. Please upgrade your browser to improve your experience and security. Founderful Family Meet the team Join us What we do Founderful Campus What's new Founderful Family Meet the team Join us What we do Founderful Campus What's new Powered by Consider Privacy Terms Founderful Family What we do Meet the team Founderful Campus Join us What's new Imprint Privacy Policy LinkedIn Crunchbase Zurich Badenerstrasse 60 8004 Zurich Switzerland Lausanne La Forge Fondation EPFL Innovation Park 1015 Lausanne Switzerland
TechBio | Deep Tech Nation Switzerland Focus Sectors Back to main menu Aerial & Space AI x Deep Tech BioTech Climate Tech & Energy MedTech Robotics Future of Compute TechBio Technical Enterprise Software Ecosystem Back to main menu Data Facts & Figures Investors and VCs Deep Tech Dashboard Directory Channels to watch Who’s Who Events Explore VC in Residence Research Back to main menu Reports Swiss Deep Tech Report 2026 VC Return Study 2025 The Deep Tech Nation Switzerland Book For Institutional Investors Pension Fund Education News Foundation Back to main menu The Foundation Founda … rd of Trustees Advisory Board Our initiatives Project Switzerland AWI Deep Tech Fund Information Platform Contact Contact us Newsletter Menu Search Focus Sectors Back to main menu Aerial & Space AI x Deep Tech BioTech Climate Tech & Energy MedTech Robotics Future of Compute TechBio Technical Enterprise Software Ecosystem Back to main menu Data Facts & Figures Investors and VCs Deep Tech Dashboard Directory Channels to watch Who’s Who Events Explore VC in Residence … 2025 The Deep Tech Nation Switzerland Book For Institutional Investors Pension Fund Education News Foundation Back to main menu The Foundation Foundation Overview Strategy & Programs Partners & Supporters People Our Team Board of Trustees Advisory Board Our initiatives Project Switzerland AWI Deep Tech Fund Information Platform Contact Contact us Newsletter Search Search Focus Sectors | Verticals TechBio TechBio is where the technological revolution meets the bi … nn General Partner Amino Collective Who’s Who in TechBio Entity Types All Award Organizations / Accelerators Business Promotion Foundation and Innovation Support Industry organisations Investors Startup Hubs University and research institutes transfer teams Basel Area Basel Area As a non-profit organization, we provide services to companies, institutions and startups interested in exploring business opportunities or innovative projects in the cantons of Basel-Stadt, Bas … Emmanuelle Charpentier, raised a USD 280 million follow-on financing in 2024 to fund clinical development of its CTX001 gene therapy programs; the company went public on Nasdaq in 2016 and has maintained its scientific operations in Zug, Switzerland, while executing global clinical trials. The Basel-to-Nasdaq trajectory of CRISPR Therapeutics is
INNOVATION AVENEW | SLAS EUROPE 2023 CONFERENCE AND EXHIBITION Join About Log In CONNECTED APPLIED Learning Search EVENTS Events Calendar Applied Liquid Handling Boot Camp SLAS Europe 2026 Conference and Exhibition SLAS2027 International Conference & Exhibition Boost Your Brand SLAS Ignite PUBLICATIONS SLAS Discovery SLAS Technology Electronic Laboratory Neighborhood Point-to-Point (P2P) e-newsletter MEMBERSHIP Membership Types and Benefits Member Directory SLAS Fellow Member Program Statement of Conduct EDUCATION Applied Liquid Handling Boot Camp SLAS Ignite APPLIED Online Learning M … s Exhibitor Hotel & Travel Information Innovation AveNEW Ignite Award New Product Award 2023 Sponsors Exhibitor Service Kit Brussels Webshop 23-26 May 2023 Brussels, Belgium Register Innovation Ave NEW Congratulations to the following companies selected to participate in Innovation Ave NEW at SLAS Europe 2023! Adaptyv Bio (Switzerland) Bionomous SA (Switzerland) ELEMENTA LABS B.V. (Netherlands) EvoEnzyme (Spain) faCellitate GmbH (Germany) FOx BIOSYSTEMS … ; OrganoTherapeutics, 2021 Innovation Ave NEW participant and New Product Award winner Iscaffpharma Highlights Technology & Innovation Ave NEW Opportunity Synthace's Experience with Innovation Ave NEW 2019 Ignite Award Winner: SEED Biosciences Who Should Apply? Interested companies must align in some fashion with the area of life sciences and technology and while not required, an established relationship with a university, bioscience incubator or research institutio … ilable for sale/distribution within the year of their conference participation. Application Process All applications are reviewed by the Innovation Ave NEW Review Panel, who will evaluate applications for technical merit and commercial feasibility as well as other criteria, inclusive of, but not limited to: Compelling science and technology Clarity of vision and market opportunity (business plan) Strength of management team Impact on the field of life sciences discovery and t … future SLAS events. Ability to opt in to consideration for the 2023 Ignite Award Beginning in January 2022, all Innovation Ave NEW companies Will be featured on the SLAS Innovation Ave NEW micro-site of APPLIED All participating companies are asked to submit a previously unpublished scientific manuscript (original research or a related revie
Inscripta CEO, Founder, Key Executive Team, Board of Directors & Employees Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors & Partners Tur … tural Experiment Station. Prior to his academic career, he spent 15 years as an award-winning scientist in the USDA - ARS. Inscripta Name Daniel Fero Eric Moessinger Roger Wyse Firm Work History Daniel Fero serves as Board Observer at Mythic Therapeutics. Eric joined +ND Capital in 2008 and was the first employee of our Silicon Valley office. He is focused on life sciences investments. Eric is currently a board member of Emulate, Visby Medical, Serotiny, AIRNA, Partillion and … tural Experiment Station. Prior to his academic career, he spent 15 years as an award-winning scientist in the USDA - ARS. Other Seats Inscripta Inscripta Inscripta Learn more by requesting a demo Compare Inscripta to Competitors Mammoth Biosciences Mammoth Biosciences focuses on clustered regularly interspaced short palindromic repeats (CRISPR) systems for the development of therapies and diagnostics. The company's offerings include gene editing technologies, use nuclea … , gene writing, and epigenetic editing. It collaborates with other companies to apply its technology. Mammoth Biosciences was formerly known as Apheleia Diagnostics. It was founded in 2017 and is based in Brisbane, California. A Adaptyv Biosystems Adaptyv Biosystems operates within the biotechnology sector and focuses on Artificial Intelligence (AI) driven protein design. The company provides laboratory services for synthesizing and testing proteins, using generative AI for p
%PDF-1.7 %���� 4 0 obj > stream H��W]o��}ׯ���@����}�&i�Ŷ@a��-�[�tD�����s��G�s 2�3s�ν�����_o�z�VZ����/;�>���~�]�}��Ii�������{�ޚie����Dy� �JWk��/C���ݭ�����W oW_q��kS�d ��|�����)��x\(���n~{wc� V�X�:&u�Y}��}��M��Z����Ʃ�������jߧaz얝��4 �S3w��~\�til��]���*u���+]����K0_�d@y���KW��z���ʆ�������f��,�v��r�9��)M ��|u�m��ZDv?��o�ݸo�q�M�;��.�� u�f��E��� ���˵�&l8ˋ�>�f$�0���� W5�z̙��i�+���x��u�iw�����a���?�Or� �v�/Y;�m�_kT�M��{�nڧ� ew> ��� a�?�ߜ�����ܮ��؏ٽy ��TG�2��t��M��F� ʏ��� �ћ����0ts��,I��K�o�i�=��n�/������m���������D�X��^���^��f�� +�0o� V���M ��}�T�u�$l��סj�9�N� … , +�LܸR BDXx{ߴ �m��t~J��X"�� '��r�"��X���n��� Y�� �o��{��xR٢{��B > stream application/pdf DemographicChart_OrgType 2024-07-20T15:55:42-04:00 2024-07-20T15:55:42-04:00 2024-07-20T15:51:36-04:00 Adobe Illustrator 28.5 (Windows) uuid:b19c4de5-ba11-4592-8b2d-656a96985621 xmp.did:22db91e2-a4a8-704c-af36-42546c69fe4d uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:3ae577aa-2b78-47a7-b83b-430c1352e487 xmp.did:538a8e61-a26e-514a-8a0a-b48ba011f36b uuid:5D20892493BFDB11914A8 … ������������py�>��S�EpѫC�H8q�W���Jx���19m��2 > endobj 22 0 obj > stream application/pdf OutlineContinents asia continents vector planete hand black outline europe americas map world drawn white icon idea africa eurasia australia america east west nord south concept sketch ink pencil illustration background shape travel graphics regions ocans globe hand drawing eco background Adobe Illustrator 28.5 (Windows) 2024-07-20T17:55:26-04:00 2024-07-20T17:55:27-04:00 2024-07-2 … FDAD5311E78BAA87BA0D024513 uuid:18EA74FDAD5311E78BAA87BA0D024513 converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:4d27d493-fe72-e143-8e04-1c6875f6bb5a 2024-07-20T17:55:25-04:00 Adobe Illustrator 28.5 (Windows) / Print Document AIRobin 1 False False 209.999998 139.999999 Millimeters Cyan Black Default Swatch Group 0 White CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Black CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 Charcoal CM … 3f17f01ba xmp.did:b825ec08-4fda-ca41-9dd2-7c17f37f4f8e proof:pdf converted from application/x-indesign to application/pdf Adobe InDesign 19.4 (Windows) / 2024-06-14T10:53:33-04:00 saved xmp.iid:fc4b04ab-1bf6-8f46-9378-a843f17f01ba 2024-07-20T14:50:56-04:00 Adobe Illustrator 28.5 (Windows) / saved xmp.iid:f05427fc-36ed-8d49-8f14-868f56720bd3 2024-
The Week in Swiss Startups (30.6-4.7.2025) - Week #27 The Week in Swiss Startups Subscribe Sign in The Week in Swiss Startups (30.6-4.7.2025) - Week #27 The newsletter features 13 startups and 2 exits. More than $180M in one week. Beekeeper exit! Italian VCs increased investments in CH companies! Gian Sbetta Jul 07, 2025 ∙ Paid 2 Share Join 5750+ VCs, angels, founders, and startup operators. Subscribe now for free! Subscribe Hi there, Swiss startups announced $180M+ last week. This was fueled by Climeworks that raised a $162M growth round. Worth mentioning that seed rounds avg. deal size is in
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Crowdsourced Protein Design: Lessons From the Adaptyv EGFR Binder Competition | bioRxiv Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Crowdsourced Protein Design: Lessons From the Adaptyv EGFR Binder Competition Tudor-Stefan Cotet , Igor Krawczuk , Filippo Stocco , Noelia Ferruz , Anthony Gitter , Yoichi Kurumida , Lucas de Almeida Machado , Francesco Paesani , Cianna N. Calia , Chance A. Challacombe , Nikhil Haas , Ahmad Qamar , Bruno E. Correia , Martin Pacesa , Lennart Nickel , Kartic Subr , Leonardo V. Castorina , Maxwell J. Campbel … burgh, , EP/S02431X/1 University of Edinburgh School of Biological Sciences PhD Scholarship, , Royal Society's University Research Fellowship, , UKRI Biotechnology and Biological Sciences Research Council (BBSRC) grant, , BB/T00875X/1 K Research and Innovation (UKRI) Biotechnology and Biological Sciences Research Council Strategic Longer and Larger award, , BB/X003027/1 Air Force Office of Scientific Research, , FA9550-20-1-0351 San Diego Fellowship, , National Science Founda … hroughput Computing, , Jeanne M. Rowe, , Unidel Distinguished Graduate Scholars Fellowship and NSF NAIRR Pilot, , 240064 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted April 24, 2025. Download PDF Data/Code Email Thank you for your interest in spreading the word about bioRxiv
The Protein Design Competition Is Back! - Adaptyv Bio Adaptyv Bio Subscribe Sign in The Protein Design Competition Is Back! 🌍 The biggest decentralized science experiment of 2025 starts now! Adaptyv Bio Oct 21, 2025 8 1 1 Share The protein design competition returns: we’re inviting scientists, engineers, and hackers from around the world to help design new proteins capable of neutralizing the Nipah virus, a pathogen with up to 75% mortality and no effective treatment. All you need is a laptop to participate: submit your computational protein designs, and Adaptyv will synthesize and experiment … ition are available on the Proteinbase competition page. You’ll also be able to submit your designs there once submissions open: ➡️ proteinbase.com/competitions/adaptyv-nipah-competition 8 1 1 Share Discussion about this post Comments Restacks dcianferoni Nov 24, 2025 hey! how is the optimization task measured? I mean, will be hard to have top ipSAE for sequences based on existing binders, they will be buried below de-novo sequences with top-scoring ipSAE no? Reply Share Top
Jobs and Employment at Adaptyv Biosystems | Simplify Jobs Home Matches Jobs Job Tracker Documents Services Refer Log in Back Work Here? Claim Your Company Adaptyv Biosystems Work Here? Claim Your Company AI-driven protein design and synthesis platform Website Open user menu Share Adaptyv Biosystems Work Here? Claim Your Company AI-driven protein design and synthesis platform Website Open user menu Share Overview Reviews Interviews Overview Adaptyv Biosystems designs and sells custom proteins—such as antibodies and enzymes—produced using AI-guided design and cell-free synthetic biology. Its pro
Adaptyv Biosystems raised CHF 2.5 million in a pre-seed funding - BioAlps Skip to content Bio Alps FIND A HEALTH VALLEY ACTOR Menu Search News BioAlps news BioAlps 20 years Events About Mission Organization Members and Strategic Partners BioAlps Awards Media Center News Events BioAlps events Life science events About Mission Organisation Executive Committee BioAlps Team -- Members and Strategic Partners BioAlps Awards Media Centre Publication -- --> BioAlps Event Formats Business Opportunities Community Membership Registration The BioAlps Community Business opportunities Community Membership R … lopment of new therapies for previously untreatable diseases and for industrial application. “The proteins found in our bodies and in nature are the most advanced nanotechnology we know of. We’re building a next-gen protein engineering platform to harness this incredible potential”, say Daniel Nakhaee-Zadeh Gutierrez, Amir Shahein, Moustafa Houmani, and Julian Englert, founders of Adaptyv Biosystems. The company has raised CHF 2.5 million in a pre-seed fundi
Adaptyv Biosystems Sàrl - Venture Kick Get the Kick 1234+ KICKS Portfolio Jury Newsroom About us DONATIONS & LEGACY --> Login Username Password Forgot password / Create a new password EN DE FR Login Get the Kick 1234+ KICKS Portfolio Jury Newsroom About us DONATIONS & LEGACY EN DE FR Get the Kick 1234+ KICKS Portfolio Jury Newsroom About us DONATIONS & LEGACY Login Back to overview At Adaptyv Bio we're building a next-generation protein foundry. We combine advanced robotics, microfluidics and synthetic biology techniques to create fully automated protein engineering workcells that allow users … pletes first investment deal (startupticker.ch) 15.03.2022 First Wingman Campus Fund supported startups revealed (startupticker.ch) 14.02.2022 Adaptyv Biosystems raises USD 2.5 million to create the world’s largest protein design database (venturekick.ch) 14.02.2022 CHF2.5 million to build up the most powerful protein engineering platform (startupticker.ch) 15.09.2021 CHF 40,000 for startups developing the next-generation of antibody engineering, enjoyable prosthetics, and an
Protein Design Demo with Claude Code and Adaptyv API | Julian Englert posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree … ade a quick demo to test how agents can interact with protein design models and submit the proteins to our lab for testing. This closes the loop between the computational design and the experiment validation We queued up a bunch of agent-designed proteins for wet lab validation, will release the results in a couple weeks on Proteinbase Under the hood this uses the Anthropic agent sdk, our own Adaptyv API and the demo protein design models from design-a-protein.com Get in touc
%PDF-1.7 1 0 obj > endobj 2 0 obj > endobj 3 0 obj > /ProcSet 6 0 R >> /MediaBox [0 0 612 792] /CropBox [0 0 612 792] /Contents 4 0 R /Thumb 13 0 R >> endobj 4 0 obj > stream q 612 0 0 792 0 0 cm /Im0 Do Q endstream endobj 5 0 obj 31 endobj 6 0 obj [ /PDF /Text /ImageC ] endobj 7 0 obj > endobj 8 0 obj > stream ����JFIF�� ICC_PROFILE mntrRGB XYZ acspAPPL���- desc�|cprtx(wtpt�bkpt�rXYZ�gXYZ�bXYZ�rTRC gTRC bTRC desc"Artifex Software sRGB ICC Profile"Artifex Software sRGB ICC ProfiletextCopyright Artifex Software 2011XYZ �Q�XYZ XYZ o�8��XYZ b����XYZ $����curv
Daniel Nakhaee-Zadeh Gutierrez - Co-Founder at Adaptyv Biosystems | The Org Platform Enrich Pricing Log in Sign up Adaptyv Biosystems Daniel Nakhaee-Zadeh Gutierrez Unverified Daniel Nakhaee-Zadeh Gutierrez Co-Founder Contact Daniel Nakhaee-Zadeh Gutierrez has a diverse work experience in the field of bioengineering and biotechnology. Daniel is a co-founder of Adaptyv Biosystems, a company established in 2020. Prior to that, they gained experience at Harvard University as a Master Thesis student, focusing on the development of tolerogenic vaccines for autoimmune disease treatment. Daniel als
Adaptyv Biosystems secures funding from Y Combinator - EPFL Homepage of the site Skip to content Skip to main navigation Skip to side navigation Skip to search Contact us News EPFL ENAC SB STI IC SV CDM CDH All Show / Hide search form Search Hide search form Search Search Login EN FR EN DE Menu News EPFL ENAC SB STI IC SV CDM CDH All Adaptyv Biosystems secures funding from Y Combinator Import & publish the news × Are you sure you want to import this news into ? This news will be sent to its subscribers. Yes No © 2021 Adaptyv Biosystems Team ( From right to left: Julian Englert, Moustafa
Adaptyv Biosystems Inc. Asset Profile | Preqin Skip to main content Products Our products Preqin Pro Alternative assets data platform Private Markets Research Industry research Term Intelligence Benchmark LPA terms Preqin Benchmarks Industry's leading performance data Preqin Sustainability ESG data and insights Company Intelligence Companies & deals data Enterprise Data Solutions Flexible data delivery solutions Transaction Intelligence A $5.4tn transaction repository Client stories What our clients say Quick Links Our data Asset classes we cover Create a free account Newsletter Contr … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Quick Links Our data Asset classes we cover Create a free account Newsletter Contribute data Contact us Insights+ Private markets research Homepage Browse reports Search Search the research library Webinar recordings Join conversations with our analysts Meet the analysts Meet the team behind the reports Learn more Learn more about Private Markets Resear … r analysis Keep up with market trends Spot new business opportunities Benchmark fund terms Navigate private credit investing Insights+ Homepage Search Webinar recordings Meet the analysts Learn more News & content Homepage Events Free Benchmarks Data coverage map Preqin Profiles Preqin Academy Compensation calculator About Who we are Our corporate responsibility Partners Press hub Careers Contact us QuickLinks Our data Asset classes we cover Create a free account Newslett … ed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers. Request demo Adaptyv Biosystems Inc. - overview Established 2020 Location Lausanne, -, Switzerland Primary Industry Biotechnology About Based in Switzerland and founded in 2020, Adaptyv Biosystems Sàrl operates as a Biopole-based company. Daniel Nakhaee-Zadeh Gutierrez, Amir Shahein, Moustafa Houmani, and Julian Engler … go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more. Sign in Request demo Our Company Who We Are Our Corporate Responsibility Partners
8x improvement in EGFR binding affinity: winning the Adaptyv Bio protein design competition | Cradle ')"> Platform Solutions Company Licensing Resources Sign in Talk to sales ')"> Talk to sales 8x improvement in EGFR binding affinity: winning the Adaptyv Bio protein design competition 8x improvement in EGFR binding affinity: winning the Adaptyv Bio protein design competition 130 teams competed in Adaptyv Bio’s protein design competition to create novel EGFR-binding proteins. Cradle's platform achieved first place with a binding affinity of 1.21nM, which is 8.2 times stronger than Merck's comme
Adaptyv: We're building fully automated labs for protein engineering | Y Combinator Open menu About What Happens at YC? Apply YC Interview Guide FAQ People YC Blog Companies Startup Directory Founder Directory Launch YC Library Partners Resources Startup School Newsletter Requests for Startups For Investors Verify Founders Hacker News Bookface Safe Find a Co-Founder Startup Jobs Log in Apply Home › Companies › Adaptyv Adaptyv We're building fully automated labs for protein engineering Y Combinator Logo Summer 2021 Active AI-powered Drug Discovery Synthetic Biology Company Jobs 0 News
Adaptyv Bio | Substack Adaptyv Bio Subscribe Sign in Home Archive About What happened in the Nipah Protein Design Competition so far? + Prediction markets for protein design For our Nipah Binder competition, we give a short overview of the submitted designs, examine which design methods were most widely adopted, and… Jan 5 • Adaptyv Bio 9 2 Latest Top Discussions Protein Design Competition — Community voting is now live! This edition, we received over 10,000 proteins from over 600 designers. Head to proteinbase.com and vote for your favorite protein designers to have… Dec 3, 2025 • Adaptyv Bio … aderboard is live! Based on popular demand, we’re also extending the submission deadline by 1 week -> now open until Sunday November 30. Nov 19, 2025 • Adaptyv Bio 1 5 Navigating the multi-property maze for therapeutic peptide design We tested MOG-DFM, a new peptide design model, in the lab and published all the sequences + data on Proteinbase. Nov 5, 2025 • Adaptyv Bio 6 Submissions for the Nipah virus protein design competition are open! We’ve already received well over 100
Benchling Launches Three Products During SynBioBeta 2026 — and Its Head of AI Hints at What Comes Next Benchling Launches Three Products During SynBioBeta 2026 — and Its Head of AI Hints at What Comes Next Nicholas Larus-Stone, Bits in Bio founder and Benchling's Head of AI, predicted from the SynBioBeta stage that 75% of all data analysis tasks in biology would be handled by AI agents within a year. Benchling shipped one of the tools to make it real before the conference was over. Aaron Blotnick May 12, 2026 San Jose, CA — May 2026 — SynBioBeta 2026 was, as always, a conference about what's c … With Ginkgo Bioworks — through its Ginkgo Datapoints offering — scientists can submit panels of antibody designs for large-scale developability screening, with results linked directly back to their originating designs in Benchling. "The lab needs to work differently if science is going to move at the pace AI enables," said Ashu Singhal, co-founder and president of Benchling. "Scientists should be able to design an experiment, order it without leaving their notebook, and have
Quantum Mechanics : Symbolism of Atomic Measurements by Schwinger, Julian; Englert, Berthold-Georg (EDT): New (2001) | GreatBookPricesUK Skip to main content AbeBooks.com Site shopping preferences Sign in My Account Basket Help Menu My Account My Purchases Sign Off Advanced Search Browse Collections Rare Books Art & Collectibles Textbooks Sellers Start Selling Help CLOSE Items related to Quantum Mechanics : Symbolism of Atomic Measurements Home Schwinger, Julian Quantum Mechanics : Symbolism of Atomic Measurements Stock Image Stock Image View Larger Image Quantum Mechanics : Symbolism of A … #39;s notation. From the Back Cover Julian Schwinger, who shared the 1965 Nobel Prize for physics with Richard Feynman and Sin-Itiro Tomonaga for his pioneering work on quantum electrodynamics, had a considerable influence on the conceptual development of modern quantum field theory. In addition to being an extremely productive researcher he was also a brilliant teacher, and this book demonstrates his outstanding ability to expose a difficult subject in a clear and concise st
How RL for protein design works and our lab's results | Julian Englert posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you
Maximizing Protein Production Workflows at PEGS Summit | Protein & Antibody Engineering Summit 2026 About About the Event FAQ Social Media Wall Get Involved Attendee List Media Gallery Testimonials Archives Agenda Search Agenda Conference Programs Training Seminars Short Courses Plenary Keynote Sessions Top Pharma Presentations Interactive Discussions Speaker Biographies Networking Events Connect & Share with Your Network Sponsor/Exhibitor Attendee Demographics + Event Features Sponsorship Opportunities Current Sponsors Current Exhibitors / Floorplan 27 Re-sign Floorplan Sponsor/Exhibi … Standard workflow for non-standard proteins Co-Hosts: Richard Altman, MS, Field Application Scientist, Thomson Instrument Company James Bowman, PhD, CTO, AI Proteins Anita Ghosh, PhD, Associate Director, Protein Engineering and Production, AstraZeneca Think Tank 2: Eliminating Bottlenecks •    What/where are the bottlenecks? •    Doing more with less •    Delivering peak performance from researchers to hosts to instruments Co-Hosts: Mark Ellis, Senior Pri … s as they share key discussion points and strategies. What can we take away and apply? 5:40 PM Close of Day Friday, May 15 Day 1 Day 2 Day 3 Day 4 Download Brochure 7:15 AM Registration Open INTERACTIVE ROUNDTABLE DISCUSSIONS 7:30 AM Interactive Roundtable Discussions with Continental Breakfast Interactive Roundtable Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic … efficiency, by leveraging synthetic biology and AI techniques. It involves the application of a massive library for multiplexed expression improvement and AI-aided optimization, and chromatography-free purification via synthetic organelles in vivo . This integrated pipeline de-risks discovery by making protein production a predictable, scalable, and automated engineering task. 9:00 AM Using High-Throughput Analytics to Streamline Multispecific Antibody Production Brian E. Ha
Quantum Mechanics: Symbolism of Atomic Measurements : Schwinger, Julian, Englert, Berthold-Georg: Amazon.com.be: Books Skip to Main content About this item About this item About this item Buying options Compare with similar items Videos Reviews Keyboard shortcuts Search opt + / Basket shift + opt + C Home shift + opt + H Orders shift + opt + O Add to basket shift + opt + K Product summary shift + opt + D Show/Hide shortcuts shift + opt + Z To move between items, use your keyboard's up or down arrows. .com.be Delivering to Brussels 1050 Update location Books Select the department you want … & Maths › Physics › Nuclear Enjoy fast, free delivery, exclusive deals and award-winning movies and TV shows. Join Prime Hardcover €117.23 Paperback €76.99 Other Used and New from €76.99 Paperback from €76.99 Hardcover from €98.09 €76.99 with 10 percent savings -10% € 76 . 99 RRP: €85.59 RRP: €85.59 €85.59 The RRP is the suggested or recommended retail price of a product set by the manufacturer and provided by a manufacturer, supplier or seller. Amazon displays the
Masatoshi Uehara, Julian Englert · Hackson · SlidesLive EN Česky English Deutsch Get an estimate Services References Blog Careers Contact Library Download Recording App SlidesLive Categories EN Česky English Deutsch Log in Get an estimate NeurIPS NeurIPS 2024 WS: AI for New Drug Modalities Hackson Hackson Dec 10, 2024 Speakers Organizer Like the format? Trust SlidesLive to capture your next event! Professional recording and live streaming, delivered globally. Learn more Sharing Copy share link Show advanced options Recommended Videos Presentations on similar topic, category or sp
We just made an app that walks you through designing a novel protein with AI from scratch. Takes about 5 minutes, requires zero biology knowledge. ➡️ design-a-protein.com The best part: we will… | Julian Englert | 21 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your … Proteinbase where we test completely novel protein sequences in a real lab. The deadline to submit proteins is this Sunday EOD. We’ve already received thousands of proteins from hundreds designers from all over the world. Adaptyv And now you can join too! …more 915 21 Comments Like Comment Share Copy LinkedIn Facebook X Jiri Damborsky Professor, Loschmidt Laboratories, Masaryk University & Founder Enantis Ltd. 6mo Report this comment Julian, amazing. GUI is beautiful and
AI Agents Design Proteins Matching Human Performance | Julian Englert posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree … opes/protein targets/structures, complex binding stoichiometries, or downstream application requirements like AAV integration or conserved/functional epitope binding. Overall, a wonderful experience. I really enjoyed the entrepreneurial spirit in SF. Thank you to the organisers! Adaptyv 14,077 followers 1mo What happens when you let frontier LLMs design proteins, and then synthesize and test them in a wet lab? In February, we ran a protein design hackathon with muni and teste
Julian Englert | SynBioBeta Speaker Γ SynBioBeta Speaker Julian Englert CEO & Founder Adaptyv Founder of Adaptyv - the cloud lab for protein designers SynBioBeta 2025 - Session Speaker AI-Powered Biological Design: Breaking Barriers or Hitting Limits? The hype around Artificial Intelligence (AI) in drug discovery and synthetic biology has never been higher. With over $5 billion invested in AI-driven biotech startups in 2024 alone, the industry is racing to redefine biological design. But are we on the cusp of true transformation, or are there fundamental limits to what AI can achieve? In t
Exhibitors Skip to main content Toggle navigation Login Search Home Tweets by SLAS Europe 2023 Icon Legend This session is not in your schedule. This session is in your schedule. Click again to remove it. Presentation Icons Short Course On Demand Exhibitors Home Exhibitors The SLAS Innovation AveNEW is a program designed specifically to enable emerging, start-up companies the opportunity to actively engage and participate in SLAS's world-class event helping to grow and scale their business as well as directly connecting them with purchasing influencers and decision-makers from around the world … l make brief presentations to a panel of judges who will bestow the SLAS Ignite Award, honoring the best start-up or emerging company. Judges will look at a combination of key concepts, marketing plan, presence, and potential; funding prospects; plan for growth, and the existence of balanced company leadership, among other qualities. Exhibitors Type here to filter the list All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # Sort by Booth Sort by Company A Favorite 410A
I am delighted to share that our team won the 1st prize 🥇 , sponsored by Debiopharm, at the Lemanic Life Science Hackathon organized by EPFL School of Life Sciences, held at EPFL in late April. We… | Tilak Purohit LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at … it 2y Edited Report this post I am delighted to share that our team won the 1st prize 🥇 , sponsored by Debiopharm , at the Lemanic Life Science Hackathon organized by EPFL School of Life Sciences , held at EPFL in late April. We presented a prototype that takes users' speech as input and evaluates their mental wellness by analyzing the vocal patterns. Based on the assessment, the core AI model predicts a mental wellness score with some confidence level. If a low score is pre
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Rajesh Devraj on biotech, venture capital, and leadership | Nucleate posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree … erever you get your podcasts. This episode was co-produced with Kickfund , a VC fund investing in the most promising Swiss deeptech startups. Check out the link in the bio to learn more about them! #Entrepreneurship #FoundersJourney #StartupLife #StartupLessons #Leadership #WomenInScience #SwissInnovation #PhDToFounder #AcademicEntrepreneurship #Swisspreneur #Swissstartups #Podcast 3 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Swisspreneur 21 … erever you get your podcasts. This episode was co-produced with Kickfund , a VC fund investing in the most promising Swiss deeptech startups. Check out the link in the bio to learn more about them! #Entrepreneurship #FoundersJourney #StartupLife #StartupLessons #Leadership #WomenInScience #SwissInnovation #PhDToFounder #AcademicEntrepreneurship #Swisspreneur #Swissstartups #Podcast 114 7 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Bu … of points, not to buy time. — Angels align with the journey; VCs align with the fund—know which game you’re playing. — Design the endgame before MVP: it clarifies what to build and what not to. 🇨🇭 Smart stat: In 2024, Swiss startups raised ~CHF 2.4 bn across 357 rounds (–8.5% amount; –10.1% rounds YoY). Yet the median round size hit a record +40.7%—with seed ≈ CHF 1.4 m and early-stage ≈ CHF 4.3 m. Translation: fewer rounds, bigger bets on clear milestones. Produced by Swis … nlocked, with Director of Enterprise at RAEng, Ana Avaliani , exploring how the fellowship supports startups within the UK engineering and deep tech ecosystems. The Mathys & Squire Scaleup Quarter has also provided tailored IP advice for founders throughout our partnership with RAEng Enterprise Hub, highlighting the necessity of an effective
%PDF-1.5 %���� 249 0 obj > endobj 250 0 obj > /W [ 1 3 1 ] /Index [ 249 266 ] /Info 55 0 R /Root 251 0 R /Size 515 /Prev 785025 /ID [ ] >> stream x�cbd`�g`b``8 "9���F�4D2���� �^ DԃH�G R�H2v �.�}tAlf&0�&��$X�e �͊ �m���201�;�l;�(9JR�d�7�n%�:ɸ`��0�HlnU endstream endobj 251 0 obj > endobj 252 0 obj > stream x�c```b`�|�����#� �`6+���Ѣ������rE����� 0�b��( �9�����!��!/��O�: T��pia0�1C!��Go�3�²�g�G���T�������1�3��ű�gwfWeOS��ї�Q~#m�P�!n��ɤ�d����-�aR�*#/��& ���A���p] endstream endobj 253 0 obj > endobj 254 0 obj > stream x��Zے��}߯�[��%�����D�.�c�JicWe�Cpv h�f�ʿ��tP��T��
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Cartography of the developability landscapes of native and human-engineered antibodies | bioRxiv Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Cartography of the developability landscapes of native and human-engineered antibodies View ORCID Profile Habib Bashour , View ORCID Profile Eva Smorodina , View ORCID Profile Matteo Pariset , View ORCID Profile Jahn Zhong , View ORCID Profile Rahmad Akbar , View ORCID Profile Maria Chernigovskaya , View ORCID Profile Khang Lê Quý , View ORCID Profile Igor Snapkov , View ORCID Profile Puneet Rawa … n addition, most studies have focused on a small number of DPs ( 17 , 53 ), and apply their hypotheses to limited antibody datasets comprising of a few 100s to 1000s antibody sequences ( 7 , 10 , 34 , 52 ) or datasets not including patent-submitted antibodies or antibodies that failed during early clinical trials ( 7 , 10 , 54 ). So far, the lack of datasets with sufficient sample size has hindered an in-depth understanding of the plasticity of the antibody developability spa … gure 6C ), outlining its robustness within the advised data loss limits for its application ( 75 , 76 ). For example, we reported mean R 2 of 0.64 (sequence DPs) and 0.42 (structure DPs) with 2% data loss compared to 0.59 (sequence DPs) and 0.4 (structure DPs) with 4% data loss, at a saturation point of 20000 antibodies ( Figure 6C ). Similarly to ML Task 1, non-MWDS DPs were shown to be easier to predict ( Supp. Figure 14B ). However, the disparity in prediction accuracy bet … S), EU Horizon 2020 iReceptorplus (#825821) (to VG), a Norwegian Cancer Society Grant (#215817, to VG), Research Council of Norway projects (#300740, (#311341, #331890 to VG), a Research Council of Norway IKTPLUSS project (#311341, to VG and GKS), and Stiftelsen Kristian Gerhard Jebsen (K.G. Jebsen Coeliac Disease Research Centre, SKGJ-MED-017) (to GKS), and BBSRC (BB/V011065/1, to JG-M). This project has received funding from the Innovative Medicines Initiative 2 Joint Under … ived funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101007799 (Inno4Vac). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA (to VG). Competing interest statement V.G. declares advisory board positions in aiNET GmbH, Enpicom B.V,
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Adaptyv raises CHF 6.40M, boosts protein design success rates | BioAlps - Swiss Health Valley posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to jo … ed by Braidwell and Collective Global Management, with backing from ARK Venture Fund and General Catalyst, will help expand these facilities and accelerate Lila’s mission to transform scientific discovery. Melissa Campbell | David D'Ambrosio | Flynn Walker | Lily Hwang | John Burkhardt | Dylan Hecker | Tadhg Martinez | Katherine Allen | Charlotte Brown | Raj Patel #LilaSciences #Biotech #AIinScience #SeriesFunding #Braidwell #CollectiveGlobalManagement #ARKVentureFund #Genera
EPFL's iGEM team wins Gold in 2018 synthetic biology competition - EPFL Homepage of the site Skip to content Skip to main navigation Skip to side navigation Skip to search Contact us News EPFL ENAC SB STI IC SV CDM CDH All Show / Hide search form Search Hide search form Search Search Login EN FR EN DE Menu News EPFL ENAC SB STI IC SV CDM CDH All EPFL's iGEM team wins Gold in 2018 synthetic biology competition Import & publish the news × Are you sure you want to import this news into ? This news will be sent to its subscribers. Yes No EPFL’s 2018 iGEM team (credit: Barry Ciocco) … team with additional generous financial support from the Swiss Industry Science Fund and Nikon Instruments . The students worked on their project at EPFL’s Discovery Learning Laboratories . This year, the team was supervised by Professor Sebastian Maerkl from the School of Engineering and the Interfaculty Institute of Bioengineering , with three PhD students acting as additional instructors. Author: Nik Papageorgiou Source: Education 13.12.18 News All Education news All news
Last year I scored #1 in silico in the Adaptyv bio protein design competition but my designs crashed in 🧪 the whereas Aurelia Bustos MD, PhD made it in 🔝3 This year the competition is against the… | Andrés Miguel Torrubia Sáez LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update yo
What happened in the Nipah Protein Design Competition so far? + Prediction markets for protein design | Adaptyv Bio Services Binding Expression Thermostability Blog Team Careers API Docs Book a meeting Test your proteins Services Blog Team Careers API Docs Book a meeting Test your proteins Sign in to Foundry Adaptyv Bio Biopole Life Science Campus, Route de la Corniche 5, 1066 Epalinges, Lausanne, Switzerland [email protected] Product Binding Expression Thermostability Company Team Careers Blog Resources Docs API Legal Privacy Policy Terms & Conditions © 2026 — Adaptyv Biosystems ← Ba … d momentum clearly built over time, with a sharp increase in submissions as the deadline approached. Evolution of number of submitted designs and competition participants. Optimizing ipSAE score from Boltz-2 As in the previous competition , we selected designs for validation using an in silico metric, Boltz-2 ipSAE (more details on that metric later). This naturally fostered competition for the top spots on the leaderboard. The leading ipSAE score changed repeatedly over the
#proteindesign #biotech #ai #drugdiscovery #machinelearning #structuralbiology | Jiri Damborsky | 11 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, … (near) atomic resolution, building on the advances recognized by the 2017 Nobel Prize in Chemistry. I’m excited to say the pipeline is now delivering benchmark results: we resolved apoferritin at 2.9 Å resolution. 🎉 To celebrate (and to show what “sample-to-structure” really looks like), we put together a short video walking through the full workflow, from data collection to processing and reconstruction. PS. Huge thanks to Dominik Pinkas and for explaining me their F200, to
Weekly Tech+Bio Highlights #23 Where Tech Meets Bio Subscribe Sign in Weekly Highlights Weekly Tech+Bio Highlights #23 ALSO: New EGFR-binding Proteins, Designing Novel IBD Treatment Using Gen-AI, Toward AI-Driven Digital Organism... BiopharmaTrend , Roman Kasianov , and Andrii Buvailo, PhD Dec 17, 2024 ∙ Paid 3 3 Share Hi! This is BiopharmaTrend’s weekly newsletter, ‘Where Tech Meets Bio,’ where we talk about technologies, breakthroughs, and great companies moving the biopharma and medtech industries forward. If you've received it, then you either subscribed or someone forwarded it to you. If
Innovation Highlight: Accelerating Protein Engineering with Adaptyv Bio · Luma Discover Events Sign In Presented by EUSynBioS Follow The European Synthetic Biology Society (EUSynBioS) was founded as a student-led initiative in late 2014, we organize events to keep the Synthetic Biology community connected. Hosted By EUSynbio Society Contact the Host Report Event AI Tech Innovation Highlight: Accelerating Protein Engineering with Adaptyv Bio EUSynBioS Google Meet Registration Past Event Welcome! To join the event, please register below. Register You will be asked to verify token ownership with
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
We won the protein binder design track at the 𝗕𝗲𝗿𝗹𝗶𝗻 𝗕𝗶𝗼 × 𝗔𝗜 𝗛𝗮𝗰𝗸𝗮𝘁𝗵𝗼𝗻. Sponsors Adaptyv challenged us to design protein binders targeting 15-PGDH, an enzyme linked to… | Jude Wells | 17 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices a … ders by combining iterative multi-objective directed evolution with intelligent proposal sequences provided by the ProFam protein family language model. The basic idea is that we can start with a seed sequence (either using any scaffold protein or provided by a generative model such as BoltzGen / BindCraft / RFDiffusion), we provide the seed to our autoregressive protein family language model, ProFam, and generate a pool of 10 candidates, which typically range from 30% to 95% … ood even when starting with a strong seed candidate generated by BoltzGen. As a prize for winning, we were given $10k in Adaptyv Bio Foundry credits to experimentally test the proteins designed by our method: so we get to find out if it actually works by testing 100 designs in the lab. Thanks to my teammates: Alex Hawkins-Hooker , David Miller and Art Hoti , to the hackathon organisers Nucleate + Nucleate Germany and Adaptyv for sponsoring. And thanks to my collaborators, Jak
Julian Englert - Adaptyv Bio | Antibody Engineering & Therapeutics Europe Speaker You need to enable JavaScript to run this app. This site is part of the Informa Connect Division of Informa PLC Informa PLC About Us Investor relations Talent This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. 1 - 3 June, 2027 Congress Center Basel Switzerland Home home Agenda ADC & Bioconjugates Track Speakers Sponsors & Par
How did we win the Adaptyv Bio protein design competition? Our amazing ML engineer Constance explains our team's design strategy. Full story below - link in first comment | Cradle | 15 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your
FAST--by GETTYLAB | Portfolio, Investments & AUM | Caplight NEW Caplight raises a $16M Series A, led by BlackRock and Fin Capital → Products Solutions Resources Log in Book a demo Investors FAST--by GETTYLAB FAST--by GETTYLAB San Francisco, California f-st.com Overview FAST--by GETTYLAB is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in technology companies . They provide financing and support to facilitate the creation, development, and commercialization of innovations in deeptech . Year Founded 2019 Portfolio Companies 3 Website f-st.co
10 mutations each, starting from Cetuximab scFv and blocking mutations in the CDR regions. This rapid ideation and one-click execution led to a design that not only met but exceeded our expectations. At Cradle, zero-shot design is just the beginning. In our lab-in-the-loop pipeline, we leverage data from previous rounds to iteratively refine our models, enabling us to better navigate the protein sequence space. While our zero-shot capabilities for improving binding affinity have proven successful, it’s our active learning pipeline that transforms these initial binders into viable drug candidat … another lever to control signaling alongside dose. While the primary "showcase" application are the switchable cytokines, the authors also show applications in a switchable split luciferase, a 70x faster biosensor, and more! Applying this approach, one can keep high affinity yet release quickly when desired, resolving a long-standing kinetic trade off in PPIs and receptors. This means, in a therapeutic context, it could activate locally and deactivate systemically by dosing t
Latest A Companies | Simplify Join Now Open menu Copilot Job Application Tracker Resume Builder Employers Blog Log In Join Now Explore the Latest ' A ' Companies on Simplify A Page 1 Next → Auth0 Almanac Align Airlines Reporting Corporation Abu Dhabi Commercial Bank Aizon Axie Infinity Aurora Argo Blockchain Action Network Aimtal Arms Acres Apex Clean Energy Alphabe Insight All Native Group AMT Engineering Alan AdvantageCare Rehabilitation APPARATUS Apron ASCO Equipment Anatomy Financial Altarum Apollo io Ava Labs AIR Communities Alexander McQueen AfterShip Atlas Van Lines AriensCo A
News • Biopôle • Switzerland Home Community Overview Life sciences companies Research institutes Stories Spaces Overview Office spaces Laboratory spaces Services & Amenities Programmes Overview Biopôle Investment Programme Vanguard Accelerator Corporate Partnerships Careers Overview Postgrad Consulting Programme Master’s internships Biopôle’s podcast Jobs About Biopôle SA Campus Region History Impact Annual Review News Stories Events MyBiopôle News Stories Events MyBiopôle Home Community Overview Life sciences companies Research institutes Stories Spaces Overview Office spaces … ervice de la population 18.06 2026 Precise Health Gets a CHF 900’000 Innosuisse Grant 17.06 2026 Global Startup Ecosystem Report 2026 16.06 2026 PDC Therapeutics’ Sagitta® platform reaches clinical validation with RS-0139’s Phase 1 completion 15.06 2026 Volv Global and cross-industry leaders call for three paradigm shifts to unlock orphan drug development 12.06 2026 Aspivix has launched New Crowdfunding Campaign to Accelerate the Future of Women’s Health 11.06 2026 Comb … orld Economic Forum 2026 Technology Pioneer 08.06 2026 Impli awarded £1.4M NIHR grant to advance world-first continuous hormone monitoring patch for infertility treatment 01.06 2026 Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World Data 28.05 2026 Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors 20.05 2026 HAYA Therapeutics Announc … , and MoleSense Recognized at BIND 2026 01.04 2026 Bewe Awarded Pfizer Research Prize 2026 31.03 2026 Clinical Update | Leman Biotech Reports Progress with “Ultra-Low-Dose + Lymphodepletion-Free” CAR-T Strategy in Autoimmune and Hematologic Indications 30.03 2026 Medistri Announces its Second Sterilization Line in HU 30.03 2026 Neveso wins one of the Robotics Application of the Year Awards 27.03 2026 Evidone and SteriLease Launch Pilot Collaboration to Accelerate Deployment o … perating Room Workflows 17.03 2026 Leman Biotech Announces FDA Clearance of IND Application for META 10-19, a Metabolically Armored CD19 CAR-T Therapy 12.03 2026 Le Swiss Data Science Center inaugure son siège au Biopôle de Lausanne 12.03 2026 Pilatus Biosciences Announces First Patient Dosed in Phase 1 Trial of First-in-Class Metabolic Checkpoin
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
View Speaker Biographies | PEGS Boston Summit 2026 | May 11-15, 2026 | Boston, MA About About the Event FAQ Social Media Wall Get Involved Attendee List Media Gallery Testimonials Archives Agenda Search Agenda Conference Programs Training Seminars Short Courses Plenary Keynote Sessions Top Pharma Presentations Interactive Discussions Speaker Biographies Networking Events Connect & Share with Your Network Sponsor/Exhibitor Attendee Demographics + Event Features Sponsorship Opportunities Current Sponsors Current Exhibitors / Floorplan 27 Re-sign Floorplan Sponsor/Exhibitor Prospectus Exhibit … erience in protein engineering and biopharma industry experience focused on the application of analytical biosensor technologies and label-free interaction analysis in early-stage drug discovery. Dr. Abdiche joined the OmniAb team in September 2023 from Fair Journey Biologics where she previously served as the Chief Technology Officer. Prior to that, Dr. Abdiche previously held senior management roles at biotechnology companies and contract research organizations including Ca … T Biopharma. Frontiers in Radiopharmaceutical Therapy Richard Altman, MS, Field Application Scientist, Thomson Instrument Company Field Application Scientist Thomson Instrument Company Rich Altman has 30 years of experience in protein expression and production. In early 2019, he joined Thermo Fisher Scientific as a Field Application Scientist. Previously, he worked for several pharmaceutical companies, including Amgen, Alexion, Bayer, and Upjohn, on the cloning, expression, p … papers in Nature, Science, and Cell journal series; and two books including the award-winning “Therapeutic Monoclonal Antibodies: from Bench to Clinic.†He is an elected fellow of Society for Industrial Microbiology and Biotechnology (SIMB), the American Academy of Microbiology (ASM), American Association for the Advancement of Science (AAAS), and the National Academy of Inventors (NAI). Dr. An received his PhD from the University of Kentucky and his postdoctoral training … ields, Matt has raised over $28 million USD in venture capital and non-dilutive grant funding, brought Future Field’s novel EntoEngineâ„¢ technology to commercialization in just over a year, and co-led the growth of the team from three to 31. He now spearheads the expansion of the EntoEngineâ„¢, a world-first biotechnology that leverages transg
Zefyron | Trending Startups Of 2023 that are Redefining Entrepreneurship DE HOME MEMBERS STARTUP INVESTOR CORPORATE ACADEMIA SERVICES GLOBAL DATABASE VALUATION PITCH DECK EVENTS Services --> Blog Pricing Login Signup EN DE --> BACK Trending Startups Of 2023 that are Redefining Entrepreneurship INTRODUCTION The world of startups is constantly evolving, ever-changing and dynamic. Entrepreneurs are pushing boundaries and disrupting traditional industries with several innovative trends. Consequently, the entrepreneurship world is witnessing a thriving establishment, booming an … set Management, Reliance New Energy Solar, Ecosummit, Lynwood AG, Green Gateway Fund, Bantina Invest Ltd, Gap Technology Holding, Keshik Capital, and Chemiepark Bitterfeld-Wolfen. Investors in the latest funding round - EUR 30 million in Series Unknown Investors in the latest funding round - Reliance New Energy Limited, Aramco Ventures, ATHOS Venture GmbH, the Honourable Malcolm Turnbull AC and Keshik Capital, led by Alex Turnbull Investors in the latest funding round - May 3 … lipp Triebel Sector - Retail Investors - 83 North, Felix Capital, Upper90, TRCM Fund, L Catterton, Cherry Ventures, Sofina, Blackrock, Victory Park Capital, Abu Dhabi Investment Authority, Partech, François Nuyts, Christopher North, Village Global, Max Kronberg, David Schnieder, and Jens Wasel Investors in the latest funding round - USD 500 million in Series Unknown Investors in the latest round - Sofina, funds, BlackRock, Victory Park Capital, wholly owned subsidiary of the … 10 minutes and a business loan of up to €250,000 in two days using a self-built application and underwriting process. 8. Calvin Risk - The company assesses and manages the risks associated with the commercial application of AI algorithms by offering complete and quantitative solutions Based in - Zurich, Switzerland Total Funding - USD 1.5 million Founding Year - 2022 Sector - Software Development Investors - b2venture (formerly btov Partners), Diana zur Löwen and Wingman Vent … enture King, Wingman Ventures, HawkTail Management, S2S Ventures, Wingman Camps fund, Founders Inc, Axial VC, Y combinator, Rheingau Founders Investors in the latest funding round - USD 110K in debt financing Investors in the latest financing - Foundation for Technological Innovation (FIT) and FAST — by GETTYLAB Investors in the latest funding ro
AAIC 2026: Alzheimer’s Association International Conference | Quanterix Skip to main content Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum. Close Lucent Diagnostics Uman Diagnostics Investors Customer Portal Home Open Search Open Menu Why Quanterix? Open submenu Contact Us Contact our team for customer support, distributor inquiries, or general questions about biomarker and spatial biology solutions. Contact Us Why Quanterix? Open submenu Why Spatial Biology? Why Ultrasensitive … s Open submenu Safety Data Sheets & CoA Product Brochures Whitepapers & Application Notes Publications Interactive Datasets Webinars & Videos Academy & Trainings Posters Blog Support Company Open submenu About Us Transforming healthcare through global collaboration and cutting-edge science, Quanterix empowers researchers worldwide to advance precision health. About Us Company Open submenu About Us Leadership Careers Events & Conferences News & Media
About | AAIC | Alzheimer’s Association Alzheimer’s Association International Conference | July 12-15, 2026 | London, United Kingdom, and Online ABOUT About AAIC Learn about the world's largest forum for the dementia research community. --> AAIC Scientific Program Committee Awards The Student Experience The ISTAART Experience Traveling to London Attendee Mobile App --> Conference Policies Contact Us Future Scientific Meetings Future Scientific Meetings Visa Invitation Letter --> ABSTRACTS Abstract Submission Overview Abstract and Session Submission Guidelines Developing Topics Submissions Frequ … quest for Press Credentials REGISTER LOG IN TO AAIC REGISTRATION LOG IN TO AAIC SUBMIT AN ABSTRACT --> About AAIC On This Page: About AAIC What You Can Expect from AAIC Future Scientific Meetings People with Lived Experience and Care Partners About AAIC: An International Effort to Push Dementia Science Forward The Alzheimer’s Association International Conference (AAIC) is the largest international meeting dedicated to advancing dementia science and clinical practice. Each yea … ions until January 27. Need more time? Become an ISTAART member and extend your deadline until January 31. SUBMIT YOUR ABSTRACT --> Advance Your Career Join ISTAART, an inclusive global network of scientists, clinicians and dementia professionals. With newly discounted rates and free memberships for students, it’s easier than ever to become a part of ISTAART. Learn More Home About AAIC Abstracts Program Exhibitors Sponsors Press Have questions or need additional information?
The 37th Global Conference of Alzheimer’s Disease International | Alzheimer's Disease International (ADI) Skip to content Home Health & Care Professionals About us Donate Sitewide Search Sitewide search, click to expand Alzheimer's Disease International (ADI) About Alzheimer’s & Dementia Dementia facts & figures Risk factors and risk reduction Symptoms of dementia Living with dementia Caring for someone with dementia Clinical trials Find local support What we do Capacity building Policy Research Partnerships Accreditation ADI Conference Our members Member associations Bene … ;s Month Ways to give Staying in touch Menu Responsive nav Search for something Submit search query Search About Alzheimer’s & Dementia Expand dropdown Dementia facts & figures Risk factors and risk reduction Symptoms of dementia Living with dementia Caring for someone with dementia Clinical trials Find local support What we do Expand dropdown Capacity building Policy Research Partnerships Accreditation ADI Conference Our members Expand dropdown Member associations Benef
AAIC | July 12-15, 2026 | Alzheimer's Association Alzheimer’s Association International Conference | July 12-15, 2026 | London, United Kingdom, and Online ABOUT About AAIC Learn about the world's largest forum for the dementia research community. --> AAIC Scientific Program Committee Awards The Student Experience The ISTAART Experience Traveling to London Attendee Mobile App --> Conference Policies Contact Us Future Scientific Meetings Future Scientific Meetings Visa Invitation Letter --> ABSTRACTS Abstract Submission Overview Abstract and Session Submission Guidelines Developing Topics Submis … quest for Press Credentials REGISTER LOG IN TO AAIC REGISTRATION LOG IN TO AAIC SUBMIT AN ABSTRACT --> Alzheimer's Association International Conference ® July 12-15, 2026 London, United Kingdom, and Online A Global Forum to Advance Dementia Science Independence and Sponsorship Disclosure The Alzheimer's Association has received funding by means of sponsorship to support the delivery of our conference from multiple sponsors. The sponsors have had no editorial input or cont … Learn more about ISTAART . Get Registration Details --> Countdown to AAIC 2026 Submit an Abstract --> Plenary Speakers AAIC: Where Science Meets Community Attendees got up with the sun for today’s AAIC 5K Harbourfront Run/Walk. ISTAART members reconnect at a reception just for them. Juan Fortea, M.D., Ph.D., presents his plenary session, "Alzheimer’s Disease in Down Syndrome." Over 140 scientific sessions are happening this week at AAIC. The Alzheimer’s Association was thril … ontributions to the field of Alzheimer’s disease and dementia science. Meet the award winners . JOIN US IN LONDON FOR AAIC 2026 Conference Location Excel London Royal Victoria Dock, 1 Western Gateway London E16 1XL United Kingdom ISTAART Guide to AAIC The ISTAART Guide to AAIC video series provides step-by-step guides to help you prepare for AAIC. Watch now . Know Before You Go --> Learn What to Expect --> AMSTERDAM WEATHER Workshops and Preconferences Don't miss these hands-
AI Summit - BIO International Convention 2026 Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! June 7-10 | Philadelphia Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Glance FAQs International Visitors Why Attend Visa Invitation Letter Request Tips for International Visitors Share On Social Media For Press Media Resource Center Media Registration Engaging with the Media Request Media List Press Releases Stay in Touch Contact Us Join our mailing list … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … Amgen Genentech Boehringer Ingelheim Lilly Novo Nordisk Sanofi Academic Campus Apply for Academic Campus Exhibition Directory and Map Event Directory Exhibitor List Exhibitor In-Booth Events Event Map Exhibition Hours Exhibition Reception BIO Booths BIO Business Solutions® Pavilion BIO Member Lounge Networking BIO Receptions Other Events Social Spotlight Events Affiliate Events Application Special Experiences 5K and 1 Mile Course BIO Gives Back Headshot Lounge Matchday Loung … , high-fidelity genomic data, represents a major shift in how we understand and apply biology. Large-scale AI models trained on genomic and transcriptomic data enable researchers to predict biological behavior before running an experiment - accelerating discovery, improving clinical decision-making, and enabling more efficient d ... 3:00 PM – 4:00 PM AI Summit Session AI and Digital Health 28ABCDE Twitter LinkedIn Email Share Data Hunger, Enterprise Risks: Biomedical Data and
%PDF-1.7 %���� 2 0 obj >stream H��W�r�8��+����l7%�yw����Ȓ������� 1����h��MQ��Q��!XG)c���S�u[n�߇� ����߬�$�$�3 ��m��̶�`�>���}�T�~� �S r!Tq��n'T=Y9��[��x �(L7Qz�+��+ 3��"Q .en�m��bJS ��vx B9�wt[wKA��JJ���m;�b%��p��4,��V�(� �25��� + �8( ��R���ȇ ��&NrVl����d%�� D�.������-d�/�\�� �+�#�=��,E������MF �IYcQ���KA�s�Gu��4u��^ԍ�3�%�O�(���4~_���| 2�|Zx)B�M1*����Ff���~,kݖ�_ K�%L��0H� ��W�� ��%p�����+�6u�=��,5��J��"t�J�YѩO&��n�kWz��bI62�� ��? L�ݖ9������o���ǧM��\�^�٣P���F�!�� >6�G�����J�v�x:s�I�x�I h�v�Ǖ�drj��WM'����G��V֧ �Y�۾6�!�%|�"�E/�3�7a:� '_�ĔIc"�w
30% hit rate). Want ~100 designs? top ~10% is ~2× baseline hit rate. Binding does not mean function. Only 19 designs have neutralization annotations, and while the full neutralizers trend tighter, epitope/geometry is the primary factor. Congrats to Julian Englert and the team at Adaptyv on their hard work organizing and running the experiments. Stay tuned for deeper analysis of the results in the coming days! I'm excited to see what new methods will be published alongside the competition, the top three protocols have not been released yet. ———— Tamarind Bio is the leading provider of the cutti … equence to structure to function -- and makes it easily accessible for specific application areas. Check it out! OpenProtein.AI 2,329 followers 4mo Edited 𝐄𝐧𝐝-𝐭𝐨-𝐞𝐧𝐝 𝒅𝒆 𝒏𝒐𝒗𝒐 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐝𝐞𝐬𝐢𝐠𝐧 We’ve been hard at work making 𝘥𝘦 𝘯𝘰𝘷𝘰 protein design more accessible by onboarding new models, improving the user experience, and adding new validation tools. 𝐔𝐬𝐞𝐫-𝐟𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐆𝐔𝐈 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬 for 𝘥𝘦 𝘯𝘰𝘷𝘰 protein design - Generate pr
JPM Healthcare Conference - ImmunityBio Reaffirming our Commitment to Advertising Compliance Read our Corrective Communication here. Founder’s Vision ANKTIVA® BCG Our Science Careers Contact Patients & Caregivers ANKTIVA® Clinical Trials Patients Therapeutic Areas Bladder Cancer Glioblastoma HIV Human Papillomavirus Lymphopenia Lynch Syndrome Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer Ovarian Cancer Healthcare Providers ANKTIVA® Clinical Trials Trial Investigators Expanded Access Researchers Platforms & Modalities Trial Investigators Cell Licensing Publications Our Company About … ging tools like WhatsApp, Signal, etc. Qualified and interest candidates should apply to current openings directly through our careers page on the ImmunityBio website. ImmunityBio accepts no responsibility for any costs or charges incurred as a result of fraudulent activity. In the event you receive a suspicious message – via email, WhatsApp, or text, etc. – we advise against providing any personal information or paying any fees. If you have lost money or provided your person
JPM 2026: A STATus Report preview of upcoming health conference | STAT Skip to Main Content Manage alerts for this article Email this article Share this article Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home News Latest Series & Investigations Business Biotech … eping an eye out for at JPM 2026, and why the vibes have shifted. biotechnology Submit a correction request Reprints Alex Hogan Senior Multimedia Producer Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky . Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance wi
Healthcare Conference Skip to main content Solutions Who We Serve Insights About Us Menu Solutions Who We Serve Insights About Us Careers News Contact Us Login Global Asia Pacific Europe Latin America Middle East & Africa North America Global Back to all regions Australia & New Zealand Bangladesh Mainland China | English 中文 Hong Kong SAR, China India Indonesia Japan | English 日本 Korea | English 한국 Malaysia Pakistan Philippines Singapore Sri Lanka Taiwan, China Thailand Vietnam Back to all regions Austria Belgium Channel Islands Denmark Finland France Germany Greece Ireland Italy Luxemb … Services Helping institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of a rapidly evolving market. Global Research Leveraging cutting-edge technology and innovative tools to bring clients industry-leading analysis and investment advice. Prime Services Helping hedge funds, asset managers and institutional investors meet the demands of a rapidly evolving market. Global Liquidity Solutions Global short- … y the terms of APACHE LICENSE 2.0 or MIT License, the licensors of this Program grant you additional permission to convey the resulting work. --> | 1:45 Medical Supplies and Devices Find out what the focus is for medical device tech in 2026 | 1:45 Medical Supplies and Devices Find out what the focus is for medical device tech in 2026 View Transcript Hide Transcript Audio Descriptive Off Audio Descriptive On . - Additional permission under GNU GPL version 3 section 7 If you mo … y the terms of APACHE LICENSE 2.0 or MIT License, the licensors of this Program grant you additional permission to convey the resulting work. --> | 1:24 Small- and Mid-Cap Biotechnology Hear about the innovations driving biotech | 1:24 Small- and Mid-Cap Biotechnology Hear about the innovations driving biotech View Transcript Hide Transcript Audio Descriptive Off Audio Descriptive On . - Additional permission under GNU GPL version 3 section 7 If you modify this Program, or an … y the terms of APACHE LICENSE 2.0 or MIT License, the licensors of this Program grant you additional permission to convey the resulting work. --> | 1:36 Diversified Biopharma Industry Learn about the trends shaping healthcare | 1:36 Diversified Biopharma Industry Learn about the trends shaping healthcare View Transcript Hide Transcript Audio Desc
Samsung Biologics expands innovation pipeline with new platform and facility | Pharma's Almanac posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue
experimental medicine Since:2021 | VentureRadar search 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up All these words: Type the important words Any of these words: Type the … None of these words: Type the words you don't want Data set filters: Government Grant Incubator / Accelerator Backed Spin Off Venture Funded Select required data sets Country: Any Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia … nalysts do the work for you with VentureRadar Services . Want to add a company? Submit a Company . Company Country Status Score {cn} {cc} {cs} {gsg} Preview Upgrade now to view more search results Upgrade Now Upgrade now to view beyond page 1 of search results Access Full Search Results with a Business Account or On Demand Pass Upgrade Now Free limit reached n/a Private 100 Upgrade Upgrade for full access n/a Upgrade 35 Upgrade … {sls} Source: {s}{sle} {cn} {ct} {cf} {cc} {cd} GOVERNMENT GRANT SPIN-OFF INCUBATOR BACKED VENTURE FUNDED EQUITY CROWDFUNDED REWARD CROWDFUNDED GOVERNMENT GRANT SPIN-OFF INCUBATOR BACKED VENTURE FUNDED EQUITY CROWDFUNDED REWARD CROWDFUNDED {cw} {t} {sn} Source: {s} RANKED RESULTS NAME MATCH RESULTS {CompanyDescription} {CompanyDescription} Upgrade now to view more search results Access … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Free Sign-up for VentureRadar access You must have cookies enabled to create an accou
VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up Forgotten your password? By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie … de Therapies; Vaccines; Biotech Show more Show less Updates All Funding Insight Grant Award Conference Competition Research Website Traffic Trend Business InsighT 01 Dec 2020 Website traffic has increased in the past 3 months, up from a ranking of 676,733 to 376,314. Source: Data from alexa.com COVID-19 vaccine tracker - London School of Hygiene & Tropical Medicine Research Report 20 Sep 2020 [BioNTech; Fosun Pharma; Pfizer] listed among those developing/researching a COVID-1 … ene therapy to cost $850,000 per patient | Reuters Source: reuters.com The STEP Award (2011) Award 29 Nov 2011 Category Winner: Finances Source: The STEP Award (2011) Show less Funding Signals VENTURE FUNDED Venture-funding News Venture-funding News Venture-funding News Related Top Ranked Companies Lists Life Sciences Biologics Healthtech Sars-Cov-2 Vaccine Cancer Melanoma Immunotherapy Diagnostics Dna Rna Peptide Therapies Vaccines Biotech Website Archive 2022 2023 2024 2025 … search results. Please select a Type Funding Round Team Products & Technologies Grant Award Conference Competition Other {DETAIL_VALUE} Remove Upgrade for full access You have reached your free usage limit for today. Upgrade to a paid plan for: Unlimited search alerts 250 records per export Unlimited pages and searches Full Access from $ 60.00 per month Upgrade Now Your VentureRadar Business account is now active and your account information has been sent to … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Free Sign-up for VentureRadar access You must have cookies enabled to create an accou
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
RAADcity Expo 2026 | Longevity Products, Services & Exhibitors at RAADfest — RAADfest 0 Skip to Content Home 2026 Speakers 2026 Location & Hotel Press RAADcity Expo & Sponsors Prev RAADfest 2025 Video Library 2025 Speakers 2024 Speakers RAADfest 2024 Video Library 2023 Speakers 2022 Speakers About FAQ Contact Us Register for 2026 Open Menu Close Menu Register for 2026 Home 2026 Speakers 2026 Location & Hotel Press RAADcity Expo & Sponsors Prev RAADfest 2025 Video Library 2025 Speakers 2024 Speakers RAADfest 2024 Video Library 2023 Speakers 2022 Speakers About FAQ Cont … commitment to life extension advancements. Become a Sponsor for RAADfest 2026. Submit your application today. Submit Application Become a Sponsor for RAADfest 2026. Submit your application today. Submit Application Become a Sponsor for RAADfest 2026. Submit your application today. Submit Application Become a Sponsor for RAADfest 2026. Submit your application today. Submit Application Join us at RAADfest and position your longevity protocol at the forefront of the super longe … nce. Ray Searles- Life Extension Foundation Become a Sponsor for RAADfest 2026. Submit your application below. Sponsors representing businesses and organizations relevant to the life extension and longevity fields are invited to participate. In addition to boosting your brand with consumers and influencers, your sponsorship helps us support the advancement of radical life extension.Apply now to secure your place! Submit your application All submissions are reviewed and approv
RAADfest FAQ | Longevity Conference, Anti-Aging Summit & Radical Life Extension — RAADfest 0 Skip to Content Home 2026 Speakers 2026 Location & Hotel Press RAADcity Expo & Sponsors Prev RAADfest 2025 Video Library 2025 Speakers 2024 Speakers RAADfest 2024 Video Library 2023 Speakers 2022 Speakers About FAQ Contact Us Register for 2026 Open Menu Close Menu Register for 2026 Home 2026 Speakers 2026 Location & Hotel Press RAADcity Expo & Sponsors Prev RAADfest 2025 Video Library 2025 Speakers 2024 Speakers RAADfest 2024 Video Library 2023 Speakers 2022 Speakers About FAQ
RAADfest 2026 | The World's #1 Longevity Conference | Sept 4-6, Scottsdale, AZ 0 Skip to Content Home 2026 Speakers 2026 Location & Hotel Press RAADcity Expo & Sponsors Prev RAADfest 2025 Video Library 2025 Speakers 2024 Speakers RAADfest 2024 Video Library 2023 Speakers 2022 Speakers About FAQ Contact Us Register for 2026 Open Menu Close Menu Register for 2026 Home 2026 Speakers 2026 Location & Hotel Press RAADcity Expo & Sponsors Prev RAADfest 2025 Video Library 2025 Speakers 2024 Speakers RAADfest 2024 Video Library 2023 Speakers 2022 Speakers About FAQ Contact Us Open M … longer. Science-Based, Not Hype-Based Every speaker is selected for real-world application, not buzz. This is the science that's working now. Accessible RAADfest attendees have direct access to speakers, real conversations, and connections that don't happen at other events. Not-for-profit Mission RAADfest is produced by the Coalition for Radical Life Extension , a 501(c)(3) not-for-profit. The mission is the movement, not the margin. A Decade of Impact Launched 2016, RAADfes
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
ARDD 2026 Main Past events ARDD 2025 ARDD 2024 XPRIZE Healthspan Team Summit 2024 ARDD 2023 ARDD 2022 About Speakers Speakers 2026 Speakers 2025 Speakers 2024 Speakers 2023 Speakers 2022 Program Main Track Longevity Medicine Track Emerging Science & Technologies Workshop Physics in Aging Biology Startup Pitch Replacement in Aging Workshop Molecular Nutrition Workshop ARDD Tracks Sponsorship Sponsorship Brochure Sponsors 2025 Sponsors 2024 Sponsors 2023 Sponsors 2022 Media Scam Warning Photos Videos Media Kit Photos 2025 Photos 2024 Photos 2023 Photos 2022 Videos 2025 V … uotes Really enjoyed the breadth of talks and discussions. Michael Levitt Nobel Prize in Chemistry 2013 Stanford Phenomenal conference in the Rejuvenation Field. Steve Horvath Principal Investigator Altos Lab Where one can learn about aging scientifically, clinically and in real life. Xingli Wang Fosun Global Partner Fosun Pharma The ARDD event pioneers the future of healthy aging, driving breakthroughs in longevity research while opening a new era of cosmetic innovation Luc … ming and hearing about transformative technologies in the workshops. And Alex’s proposal to Dominika most memorable! Adam Antebi Max Planck Institute for BIology of Ageing, Cologne, Germany We are at a pivotal moment. The stars have aligned to make real progress in understanding aging and ultimately extending longevity. I found ARDD to be the nexus where diverse perspectives converge, accelerating this progress. Albert-László Barabási Northeastern University Attending for the
Jobs at LongGame Companies | LongGame You are using an outdated browser. Please upgrade your browser to improve your experience and security. Home Portfolio Team Home Portfolio Team 17 companies . 51 jobs . Join our portfolio companies.. Jobs Companies Filter jobs by skills and more Roles Enter roles Skills Enter skills Location Enter locations Company stage Enter stages Industry Enter industries Salary Select... Internships only Remote options All jobs Posted Anytime Powered by Consider Powered by Consider Privacy Terms LongGame Advisors Ltd is an Appointed Representative of Robert Quinn Advi
Optimizing Cetuximab: An update on our win of the Adaptyv 2024 competition | Cradle ')"> Platform Solutions Company Licensing Resources Sign in Talk to sales ')"> Talk to sales Optimizing Cetuximab: An update on our win of the Adaptyv 2024 competition Optimizing Cetuximab: An update on our win of the Adaptyv 2024 competition How Cradle’s 12 designs would have ranked top-12 in Adaptyv’s protein design competition Mar 31 Constance Mar 31 Constance Competition recap In our previous blog post , we shared how Cradle secured first place in Adaptyv Bio’s second protein design competition . The
PEGS Boston Summit 2026 Participant List About About the Event FAQ Social Media Wall Get Involved Attendee List Media Gallery Testimonials Archives Agenda Search Agenda Conference Programs Training Seminars Short Courses Plenary Keynote Sessions Top Pharma Presentations Interactive Discussions Speaker Biographies Networking Events Connect & Share with Your Network Sponsor/Exhibitor Attendee Demographics + Event Features Sponsorship Opportunities Current Sponsors Current Exhibitors / Floorplan 27 Re-sign Floorplan Sponsor/Exhibitor Prospectus Exhibit Services/Schedule Lead Generation Opport